The Neglected Tropical Disease Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for neglected tropical disease treatment has seen robust growth over the years. It is projected to escalate from $3.36 billion in 2024 to $3.57 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.3%.
By 2029, the neglected tropical disease treatment market is projected to reach a value of $4.52 billion, growing at a compound annual growth rate (CAGR) of 6.1%.
Download Your Free Sample of the 2025 Neglected Tropical Disease Treatment Market Report and Uncover Key Trends Now!The neglected tropical disease treatment market covered in this report is segmented –
1) By Drug Class: Anti-Parasite, Antifungal, Antibiotics, Other Drugs Class
2) By Disease Type: Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease, African Trypanosomiasis, Other Disease Types
3) By Route of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End User: Hospital, Specialty Clinics, Homecare Settings, Other End Users
The key drivers in the neglected tropical disease treatment marketare:
• Rising deployment of digital tools for disease surveillance
• A growing pipeline of new treatments and vaccines
• Increased pressure to address antimicrobial resistance
• Increasing cross-border coordination for disease elimination
The key trends in the neglected tropical disease treatment market are:
• There is an increasing trend towards developing localized treatment protocols.
• The development of low-cost vaccine platforms is a significant upcoming trend.
• The neglected tropical disease treatment market is significantly impacted by its integration with primary healthcare systems.
• Innovations in vector control solutions and integration of disease surveillance networks is an emerging trend.
Major companies in the neglected tropical disease treatment market are:
• Pfizer Inc.
• Johnson And Johnson
• Merck And Co. Inc.
• AbbVie Inc.
• Bayer AG
• Novartis AG
• Sanofi S.A.
• AstraZeneca PLC
• Abbott Laboratories
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Astellas Pharma Inc.
• Eisai Co. Ltd.
• Shionogi And Co. Ltd.
• Dr. Reddy`s Laboratories Ltd
• Cipla Ltd.
• Eiken Chemical Company Ltd
• LifeArc
• Atomwise Inc.
• Medicines Development for Global Health Ltd.
Asia-Pacific was the largest region in the neglected tropical disease treatment market in 2024